CALCIUM STEARATE

Substance profile for UNII 776XM7047L, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CALCIUM STEARATE
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
776XM7047L
Preferred term
CALCIUM STEARATE
Registry number
1592-23-0
EC number
216-472-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
2C18H35O2.Ca
Chemical structure for CALCIUM STEARATE
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
CJZGTCYPCWQAJB-UHFFFAOYSA-L
SMILES
[Ca++].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O
RxCUI
47633
PubChem
0
NCIt
C76702
INN ID
0

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LPANTOPRAZOLE SODIUM2
Calcium StearateINACTIVE INGREDIENT776XM7047LPANTOPRAZOLE SODIUM5
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LOrphenadrine Citrate Extended-Release Tablets1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LONDANSETRON4
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 200011
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LOXYBUTYNIN CHLORIDE Tablets USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets USP, for oral administration Initial U.S. approval: 20002
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE Sodium delayed-release tablets USP for oral use Initial U.S. approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 20002
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047L546f8eac-3d64-40d5-9d5e-5a5dcf71b1102
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047L49b19238-dbe7-41fd-9841-b2a0081bc4952
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only3
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20003
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDIAZEPAM TABLETS, USP2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LNitrostat ® (Nitroglycerin Sublingual Tablets, USP)1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use PANTOPRAZOLE SODIUM safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) TABLET for ORAL use. Initial U.S. Approval: 20073
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDIAZEPAM TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDonnatal Tablets3
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDonnatal Tablets2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDIAZEPAM TABLETS, USP2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LOXYBUTYNIN CHLORIDE TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDIAZEPAM TABLETS, USP3
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGemfibrozil Tablets USP, 600 mg Tablet, Film Coated Rx Only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LBELLADONNA ALKALOIDS WITH PHENOBARBITAL TABLETS Rx Only Rev. 04/051
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LSohMed™ Acid Reducer1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LFERROUS SULFATE ENTERIC-COATED TABLETS3
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LHaloperidol Tablets, USP2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDIAZEPAM TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LOXYBUTYNIN CHLORIDE Tablets USP4
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LConRx™ AR1
Calcium StearateINACTIVE INGREDIENT776XM7047LPeter Thomas Roth CC Cream - Light/Medium1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDrug Facts4
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LFERROUS SULFATE ENTERIC-COATED TABLETS2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LPhenobarbital Tablets, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGemfibrozil Tablets, USP Rev. 12/102
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LQuinidine Sulfate Tablets USP Revised: June 2009 Rx only 1907822
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047L59050278-167e-4641-a253-4e57653f8b6b2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDonnatal Tablets1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGemfibrozil Tablets USP, 600 mg Tablet, Film Coated Rx Only2
calcium stearateINACTIVE INGREDIENT776XM7047LNitrostat ® (Nitroglycerin Sublingual Tablets, USP)1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGemfibrozil Tablets, USP Rev. 12/101
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20002
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LArmour® Thyroid (thyroid tablets, USP)1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDrug Facts1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LBELLADONNA ALKALOIDS WITH PHENOBARBITAL TABLETS Rx Only Rev. 04/051
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LAcetaZOLAMIDE TABLETS USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLETS, USP2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGemfibrozil Tablets, USP Rev. 12/103
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LDIAZEPAM TABLETS, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg Rx only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LJinteli TM (northindrone acetate and ethinyl estradiol tablets, USP)1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LNitrostat (Nitroglycerin)0.4 mg USP 25 Tablets Bottle1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LHYDROCHLOROTHIAZIDE TABLETS USP Rx Only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LBELLADONNA ALKALOIDS WITH PHENOBARBITAL TABLETS Rx Only Rev. 04/051
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LHYDROCHLOROTHIAZIDE TABLETS USP Rx Only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg Rx only1
calcium stearateINACTIVE INGREDIENT776XM7047LHYDROCHLOROTHIAZIDE TABLETS, USP 40-9079 Revised — January 2008 Rx only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg Rx only2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LOndansetron Orally Disintegrating Tablets, USP2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LHYDROCHLOROTHIAZIDE TABLETS USP Rx Only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LLITHIUM CARBONATE Extended Release Tablets USP, 300 mg2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LOxybutynin Chloride Tablets, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg Rx only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg Rx only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047Lf9199a9a-e740-4b9e-993f-76961c5612693
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LMethylprednisolone Tablets, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLETS, USP2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LHYDROCHLOROTHIAZIDE TABLETS, USP 40-9079 Revised — January 2008 Rx only2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LMetoprolol Succinate Extended-Release Tablets, USP 25 mg3
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LMetoprolol Succinate Extended-Release Tablets, USP 50 mg3
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047Ld33b6027-2adf-476f-9647-d6306415261a3
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use Flomax safely and effectively. See full prescribing information for Flomax. Flomax ® (tamsulosin hydrochloride) Capsules, 0.4 mg Initial U.S. Approval: 19971
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LThese highlights do not include all the information needed to use Flomax safely and effectively. See full prescribing information for Flomax. Flomax ® (tamsulosin hydrochloride) Capsules, 0.4 mg Initial U.S. Approval: 19971
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LMetoprolol Succinate Extended-Release Tablets, USP 100 mg and 200 mg1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047L33574801-581a-4028-befd-8e0cc8b6a8921
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LOndansetron Orally Disintegrating Tablets, USP1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LMedroxyprogesterone Acetate Tablets, USP1
Calcium StearateINACTIVE INGREDIENT776XM7047LPantoprazole Sodium Delayed-Release Tablets1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047Lfemhrt ® (norethindrone acetate/ethinyl estradiol tablets)1
calcium stearateINACTIVE INGREDIENT776XM7047Ll32a4888a-b07d-4dcc-9c41-1fde50c50411
calcium stearateINACTIVE INGREDIENT776XM7047LDeltasone ® prednisone tablets, USP1
calcium stearateINACTIVE INGREDIENT776XM7047L3b95acd8-1cce-4b76-9cb2-6e9ea40e54b11
calcium stearateINACTIVE INGREDIENT776XM7047L70011405 FPO Gemfibrozil Tablets USP Revised: July 2004 Rx only1
calcium stearateINACTIVE INGREDIENT776XM7047LHalotestin ® CIII fluoxymesterone tablets, USP1
calcium stearateINACTIVE INGREDIENT776XM7047LCortisone Acetate Tablets, USP2
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3999
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LHYDROCHLOROTHIAZIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3714
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3263
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LISONIAZID TABLET [BRYANT RANCH PREPACK]1001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LNP THYROID 30 (LEVOTHYROXINE, LIOTHYRONINE) TABLET [BRYANT RANCH PREPACK]1000
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LFLOMAX CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS]401
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LHYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC. ]109
Calcium StearateINACTIVE INGREDIENT776XM7047LYOUR SKIN BUT BETTER FAIR (TITANIUM DIOXIDE AND ZINC OXIDE) CREAM [IT COSMETICS, LLC]38
Calcium StearateINACTIVE INGREDIENT776XM7047LYOUR SKIN BUT BETTER FAIR (TITANIUM DIOXIDE AND ZINC OXIDE) CREAM [IT COSMETICS, LLC]37
Calcium StearateINACTIVE INGREDIENT776XM7047LYOUR SKIN BUT BETTER LIGHT (TITANIUM DIOXIDE AND ZINC OXIDE) CREAM [IT COSMETICS, LLC]35
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]26
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LRIFATER (RIFAMPIN, ISONIAZID, PYRAZINAMIDE) TABLET, SUGAR COATED [REMEDYREPACK INC. ]26
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LGABAPENTIN TABLET, FILM COATED [ACTAVIS PHARMA, INC.]18
Calcium StearateINACTIVE INGREDIENT776XM7047LPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [JUBILANT CADISTA PHARMACEUTICALS INC.]18
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LPANTOPRAZOLE SODIUM DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]15
calcium stearateINACTIVE INGREDIENT776XM7047LPRIFTIN (RIFAPENTINE) TABLET, FILM COATED [SANOFI-AVENTIS U.S. LLC]15
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LONDANSETRON TABLET, ORALLY DISINTEGRATING [PD-RX PHARMACEUTICALS, INC.]14